Research Institute for Social Sciences, Keele University, Keele, Staffordshire, United Kingdom.
Arch Phys Med Rehabil. 2013 Apr;94(4):693-702. doi: 10.1016/j.apmr.2012.11.028. Epub 2012 Nov 28.
To explore the effects of Mobilization and Tactile Stimulation (MTS) and patterns of recovery in chronic stroke (>12mo) when upper limb (UL) "performance" has reached a clear plateau.
Replicated single-system experimental study with 8 single cases using A-B-A design (baseline-intervention-withdrawal phases); length of baseline randomly determined; intervention phase involved 6 weeks of daily MTS to the contralesional UL.
Community setting, within participants' place of residence.
Individual stroke survivors (N=8; male-to-female ratio, 3:1; age range, 49-76y; 4 with left hemiplegia, 4 with right hemiplegia) discharged from ongoing therapy, more than 1 year post stroke (range, 14-48mo). Clinical presentations were varied across the sample.
Participants received up to 1 hour of daily (Monday to Friday) treatment with MTS to the UL for 6 weeks during the intervention (B) phase.
Motor function (Action Research Arm Test [ARAT]) and motor impairment (Motricity Index [MI] arm section) of the UL.
UL performance was stable during baseline for all participants. On visual analysis, improvements in motor impairment were seen in all participants, and clinically significant improvements in motor function were seen in 4 of 8 participants during the intervention phase. Latency between onset of intervention and improvement ranged from 5 to 31 days (ARAT) and from 0 to 28 days (MI). Improvements in performance were maintained on withdrawal of the intervention. Randomization tests were not significant.
MTS appears to improve UL motor impairment and functional activity many months, even years, after stroke onset. Improvement can be immediate, but more often there is latency between the start of intervention and improvement; recovery can be distal to proximal.
探索 Mobilization 和触觉刺激(MTS)对慢性中风(>12 个月)患者上肢(UL)“表现”达到明显平台期后的影响及其恢复模式。
采用 A-B-A 设计(基线-干预-撤药阶段)对 8 个单例进行复制性单系统实验研究;基线长度随机确定;干预阶段涉及对非优势侧 UL 进行为期 6 周的每日 MTS。
社区环境,在参与者居住的地方。
8 名中风幸存者(男女比例 3:1;年龄范围 49-76 岁;4 例左侧偏瘫,4 例右侧偏瘫),从正在进行的治疗中出院,中风后超过 1 年(范围 14-48 个月)。样本中的临床表现各不相同。
在干预(B)阶段,参与者接受长达 1 小时的每日(周一至周五)治疗,对 UL 进行 MTS。
UL 的运动功能(动作研究上肢测试 [ARAT])和运动障碍(运动指数 [MI] 上肢部分)。
所有参与者在基线期 UL 表现均稳定。通过视觉分析,所有参与者的运动障碍均有所改善,在干预阶段,8 名参与者中有 4 名的运动功能有明显改善。干预开始与改善之间的潜伏期从 5 天到 31 天(ARAT)和 0 天到 28 天(MI)不等。停止干预后,运动表现仍有改善。随机化检验无显著意义。
MTS 似乎可以改善中风后数月甚至数年的 UL 运动障碍和功能活动。改善可能是即时的,但更常见的是干预开始与改善之间存在潜伏期;恢复可以是从远端到近端。